RESPeRATE Ultra
All the power of the original RESPeRATE in just half the size. RESPeRATE is the only FDA-cleared, non-drug, medical device clinically proven to lower high blood pressure with no side effects.
RESPeRATE utilizes a patented technology to deliver certain kinds of breathing exercises. When these exercises are performed for as little as 15 minutes a day, 3-4 times a week they have been shown to significantly lower blood pressure with no side effects. The RESPeRATE is easy to use and comes with everything you need to get started.
RESPeRATE Ultra also includes a first-of-its-kind Interactive Tutorial that effortlessly guides you to become an expert in harnessing the natural power of your breathing. It’s like having your own personal breathing coach.
Features: Computerized unit with smart algorithm Built in memory to track progress Interactive tutorial Small, portable design Large, enhanced display Fewer buttons, simple menus Detachable sensor belt Over the Counter No Contraindications FDA Approved as an adjunctive treatment for hypertension and stress reduction
About RESPeRATE
These therapeutic breathing exercises are difficult to effectively perform without the interactive, personalized coaching that RESPeRATE provides.
RESPeRATE Reduces Severity of Hypertension
Proven to Work
RESPeRATE has been written about in many leading medical journals, magazines, and books, including the American Heart Association's, "Hypertension Primer" and the Mayo Clinic's, "On High Blood Pressure".
RESPeRATE's therapeutic benefit was validated in ten separate clinical studies, delivering 14/8 mmHg average sustained blood pressure reductions
Over 150,000 patients are using and witnessing the benefits of RESPeRATE.
A Strong Medical & Scientific Foundation
Guided by a world-renowned Scientific Advisory Board, InterCure, the maker of RESPeRATE, is committed to evidence-based medicine, clinical validation and a sound scientific foundation.
The company has already demonstrated strong clinical validation for RESPeRATE. Clinical achievements for RESPeRATE, our non-drug medical device for lowering blood pressure, include:
The first and only medical device indicated for the adjunctive treatment of hypertension. 14/8 mmHg average sustained blood pressure reductions within 8 weeks. No side effects, no drug interactions. Results of ten clinical trials were published in peer-reviewed medical journals. [1-5]
RESPeRATE warranty: 1 year
RESPeRATE Peer-Reviewed Articles (All links open in a new window)
"Treating hypertension with a device that slows and regularizes breathing: A randomised, double-blind controlled study." Schein M, Gavish B, Herz M, Rosner-Kahana D, Naveh P, Knishkowy B, Zlotnikov E, Ben-Zvi N, Melmed RN. Journal of Human Hypertension ; 2001, 15:271-278.
"Breathing-control lowers blood pressure." Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B. Journal of Human Hypertension ; 2001, 15:263-269.
"Device-guided breathing exercises reduce blood pressure - Ambulatory and home measurements." Rosenthal T, Alter A, Peleg E, Gavish B.American Journal of Hypertension ; 2001, 14:74-76.
"Nonpharmacologic Treatment of Hypertension by Respiratory Exercise in the Home Setting." E Meles, C Giannattasio, M Failla, G Gentile, A Capra, G Mancia. American Journal of Hypertension ; 2004, 17:370-374.
"Graded Blood Pressure Reduction in Hypertensive Outpatients Associated with Use of a Device to Assist with Slow Breathing." W Elliott, J Izzo, Jr., WB White, D Rosing, CS Snyder, A Alter, B Gavish, HR Black. J Clin Hypertens ; 2004 6(10): 553-559.
"Non-Pharmacological Treatment of Resistant Hypertensives by Device-Guided Slow Breathing Exercises." Viskoper , R, Shapira, I, Priluck, R, Mindlin, R, Chornia, L, Laszt, A, Dicker, D, Gavish, B, Alter, A. American Journal of Hypertension ; 2003; 16:484-487.
"High Blood Pressure Reduction in Diabetics with Interactive Device-Guided Paced Breathing: Final Results of a Randomized Controlled Study." MH Schein, A Alter, S Levine, T Baevsky, A Nessing, and B Gavish. Journal of Hypertension 2007; 25 (2), S192.
"Blood pressure change following 8-week, 15-minute daily treatment with paced breathing guided by a device: A korean multi-center study." J H Bae, J H Kim, K H Choe, S P Hong, K S Kim, C H Kim and W H Kim. Journal of Clinical Hypertension , 2006, 8 (5), A43.
"Device-Guided Breathing to Lower Blood Pressure: Case Report and Clinical Overview." W Elliott, J Izzo Medscape General Medicine, 2006; 8(3) - (Requires free registration to read the complete article.)
Meles E, Giannattasio G, Boff L et al. Italian Society of Hypetension National Meeting, Bologna Italy, September 2002.
"Device-Guided Paced Breathing Reduces Blood Pressure: Ambulatory and Office Measurements." Aydin et al. European Society of Hypertension 2008.
How it works
How RESPeRATE Lowers Blood Pressure
RESPeRATE utilizes a patented technology to pace your breathing from the normal range of 14 to 19 breaths per minute to the "therapeutic zone" of under 10 breaths per minute.
Within a few minutes into the exercise the muscles surrounding the small blood vessels dilate [relax], thereby allowing blood to flow more freely, resulting in lower blood pressure. Sympathetic neural activity is reduced, decreasing peripheral resistance in the small blood vessels and lowering blood pressure. [RESPeRATE relaxes the muscles surrounding the small blood vessels]
The RESPeRATE's pacing technology, enables you to perform these therapeutic breathing maneuvers effortlessly.
Your breathing returns to normal after each session but the beneficial impact on your blood pressure accumulates.
With regular use of the RESPeRATE significant and sustained reduction in blood pressure can be achieved. After each session of device guided breathing, respiration returns to normal, but the beneficial impact on blood pressure accumulates. Used routinely for 15 minutes a day, RESPeRATE demonstrates a significant, sustained blood pressure reduction beyond the reduction from concurrent treatments.
PRECAUTIONS
Do not use this device without consulting your physician if you suffer or have suffered in the past from: active ischemic heart disease/unstable angina, severe congestive heart failure, chronic atrial fibrillation, stoke resulting in permanent impairment, chronic renal failure, severe asthma, chronic obstructive pulmonary disease (COPD), like chronic bronchitis and emphysema, or major organ failure.
For best results use for 15 minutes per session, at least 3 or 4 times per week.
Full details to operate RESPeRATE and perform the breathing exercises can be found in the RESPeRATE user manual .
